Press Releases 

CEO Gerald Vardzel will be a Panelist at Life Sciences PA's Leadership Panel and Networking Brea

Helomics CEO, Gerald Vardzel will sit on a panel at Life Science Pennsylvania's Leadership Panel and Networking Breakfast on Friday, April 21st 2017. The event will run from 7:30 AM to 9:30 AM at Crowne Plaza in King of Prussia, PA. Alongside our CEO will be John Ryan, J.D., President and CEO of Unilife Corporation. If you are interested in a discussion about "rapid growth, unpredictible change, and organizational success," visit: https://life-sciences-pennsylvania.ticketleap.com/leadership-roundtable/details to find out more and register to attend!

Helomics® Corporation and SCOPE International USA, Inc. Announce the Completion of a Strategic Agree

Helomics-SCOPE USA partnership provides pharmaceutical and diagnostic companies with a single partner capable of providing a complete range of pre-clinical and clinical trial services. PITTSBURGH– March 23, 2017 - Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotechnology industries, and SCOPE International USA, Inc. (SCOPE USA), the North American office of an independent, full-service, contract research organization offering a complete range of clinical development services to the pharmaceutical, biotechnology, and medical device industries, today announced the completion

Helomics® Corporation and The University of Pittsburgh Announce the Completion of a Broad Strategic

The University’s Innovation Institute will collaborate with Helomics to co-develop new intellectual property and to commercialize existing University technologies. PITTSBURGH– March 21, 2017 - Helomics® Corporation (Helomics), a privately-held, healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and The University of Pittsburgh - Of the Commonwealth System of Higher Education (Pitt), today announced the completion of a Master Research and Development Collaboration Agreement. Under the terms of this five-year agreement, Helomics will collaborate with the University’s Innovation Institute to co-develop new intelle

Archive
 Follow Us
  • LinkedIn Social Icon
  • Facebook Basic Square
  • Twitter Basic Square

© 2020 Helomics Corp. All rights reserved.

  • White Twitter Icon
  • Facebook - White Circle
  • White LinkedIn Icon